Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Attenuated Chemotherapy in Lung Cancer Patients With Comorbidities or Age > 70
NCT05800587Phase 2Recruiting
- Sponsor
- Fox Chase Cancer Center
- Start
- Feb 2023
- Primary completion
- Aug 2028
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Targeted Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, pemetrexed, Paclitaxel Micelles for Injection, paclitaxel, docetaxel in lung cancer, sponsored by Fox Chase Cancer Center. Started Feb 2023; status: recruiting.
02
Drugs
carboplatinpemetrexedPaclitaxel Micelles for Injectionpaclitaxeldocetaxel
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT05800587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05800587.